Literature DB >> 10862648

Minimal change nephrotic syndrome associated with rifampicin treatment.

K Kohno1, Y Mizuta, T Yoshida, H Watanabe, H Nishida, K Fukami, S Iida, R Haramaki, Y Wada, O Tamai, K Tamaki, S Kato, M Morimatsu, S Okuda.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10862648     DOI： 10.1093/ndt/15.7.1056

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN： 0931-0509            Impact factor:   5.992


× No keyword cloud information.
  5 in total

1.  Acute Tubular Necrosis and Thrombocytopenia Associated With Rifampin Use: Case Report and Review.

Authors:  Emma L Smith; Laura Bywater; Rebecca Pellicano; Grant A Jenkin; Tony M Korman
Journal:  Open Forum Infect Dis       Date:  2022-05-17       Impact factor: 4.423

2.  Rifampicin-induced minimal change disease is improved after cessation of rifampicin without steroid therapy.

Authors:  Dong Hyuk Park; Sul A Lee; Hyeon Joo Jeong; Tae-Hyun Yoo; Shin-Wook Kang; Hyung Jung Oh
Journal:  Yonsei Med J       Date:  2015-03       Impact factor: 2.759

3.  Minimal change disease related to rifampicin presenting with acute renal failure during treatment for latent tuberculosis infection: A case report.

Authors:  Jee-Seon Kim; Kyong-Ju Kim; Eun-Young Choi
Journal:  Medicine (Baltimore)       Date:  2018-06       Impact factor: 1.889

4.  Rifampin-associated tubulointersititial nephritis and Fanconi syndrome presenting as hypokalemic paralysis.

Authors:  Hong Ki Min; Eun Oh Kim; Sang Ju Lee; Yoon Kyung Chang; Kwang Sun Suh; Chul Woo Yang; Suk Young Kim; Hyeon Seok Hwang
Journal:  BMC Nephrol       Date:  2013-01-16       Impact factor: 2.388

5.  Rifampicin-Associated Secondary Minimal Change Disease Presenting with Nephrotic Syndrome in a Pulmonary Tuberculosis Patient.

Authors:  Satyanand Sathi; Anil Kumar Garg; Manoj Kumar Singh; Virendra Singh Saini; Devinder Vohra
Journal:  Case Rep Nephrol       Date:  2021-04-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.